何氏眼科 (301103.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.6x

Market Cap

CNY 2.59B

MomentumView details →

1D Return

−2.09%

YTD Return

−16.36%

RSI (14)

48.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.6x

Market Cap

CNY 2.59B

RSI (14)

48.4

MomentumView details →

1D Return

−2.09%

YTD Return

−16.36%

ProfitabilityView details →

Gross Margin

41.14%

Net Margin

2.49%

EBITDA Margin

12.86%

ROE (TTM)

1.43%

ROA (TTM)

1.23%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

+0.36%

EPS YoY

+214.83%

FCF YoY

+46.63%

Revenue CAGR 3Y

+4.58%

EPS CAGR 3Y

−7.71%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

8.52x

Quick Ratio

8.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.11B

Net Income (TTM)

27.49M

Op. CF (TTM)

153.07M

Latest newsMore news →

He Eye Hospital announced its first-half 2026 results: revenue of 585 million yuan, up 4.46% year-on-year; net profit attributable to shareholders of 41.53 million yuan, down 6.30% from 44.32 million yuan in the same period of 2025; non-recurring adjusted net profit of 34.76 million yuan, down 6.67%.9d ago

Similar companies

皓宸医疗002622.SZ 光正眼科002524.SZ 澳洋健康002172.SZ 普瑞眼科301239.SZ *ST美谷000615.SZ 盈康生命300143.SZ

Latest newsMore news →

He Eye Hospital announced its first-half 2026 results: revenue of 585 million yuan, up 4.46% year-on-year; net profit attributable to shareholders of 41.53 million yuan, down 6.30% from 44.32 million yuan in the same period of 2025; non-recurring adjusted net profit of 34.76 million yuan, down 6.67%.9d ago